Simultaneous alterations in ovaries and bone as a result of Polycystic Ovary Syndrome

Main Article Content

Bonfá, ALO
Alves, ED
Fabrício, V
Nonaka, KO
Anselmo-Franci, JA
Achcar, JA
Luís Henrique Montrezor


Polycystic ovary syndrome (PCOS) is one of the most widely recognized endocrine disorders affecting reproductive-age women. The etiopathogenesis and mechanisms of this syndrome remain unclear. Diagnosis requires two of the following: polycystic ovaries, oligo- or anovulation, and hyperandrogenism. Most women with PCOS display conditions such as metabolic abnormalities, diabetes, obesity, cardiovascular disease, and/or bone dysfunction. Considering the ethical limitations of human studies, animal and cell culture models that reflect some features of PCOS are important for investigation of this syndrome. The aim of the present work was to study some of the endocrine relationships between ovaries and bone tissue in a polycystic ovary syndrome animal model. The study was performed using an estradiol valerate PCOS-induced rat model (n = 30) and bone mesenchymal stem cell cultured from bone marrow of those animals. It was hypothesized that changes of the endocrine relationship between ovaries and bones could be observed in from in vivo animal model and in vitro cell culture assays. The ovarian morphological and endocrine changes seem to be correlated with endocrine, biophysical, and biomechanical changes in bone properties. Mesenchymal stem cells obtained from PCOS-induced rats, cultured for up to 21 days and differentiated into osteoblasts, presented lower viability and reduced mineralization of the extracellular matrix. Taken together, these results indicate important endocrine and structural effects of PCOS in ovaries and bones, contributing to part of the understanding of the pathophysiological mechanisms of PCOS.


Download data is not yet available.

Article Details

How to Cite
Bonfá, A. L. de O., Alves, E. D., Fabrício, V., Nonaka, K. O., Anselmo-Franci, J. A., Achcar, J. A., & Montrezor, L. H. (2021). Simultaneous alterations in ovaries and bone as a result of Polycystic Ovary Syndrome. International Journal of Advances in Medical Biotechnology - IJAMB, 3(2).
Original Article